The earnings call depicted a challenging quarter for Bruker, with significant revenue declines and reduced guidance due to market, tariff, and foreign exchange headwinds. Despite these challenges, Bruker is implementing substantial cost-saving measures and continues to innovate, particularly in diagnostics and new product launches. However, the negative aspects, such as the revenue and EPS decline, along with the challenges in U.S. academic funding, outweigh the positives.

Company Guidance -

Q3 2025

During Bruker Corporation's Second Quarter 2025 Earnings Conference Call, the company provided updated guidance for the fiscal year 2025, anticipating approximately flat constant exchange rate revenue growth. The organic revenue is expected to decline by 2% to 4% for the year, with non-GAAP EPS projected to decrease by a mid-teens percentage year-over-year. The company faced significant challenges in the quarter due to lower-than-anticipated bookings and revenues, with a book-to-bill ratio in the BSI segment in the mid-0.9 range. Revenue for Q2 2025 was reported at $797.4 million, a 0.4% decrease year-over-year, with a 7% organic decline. Non-GAAP operating margin decreased by 480 basis points to 9%, and non-GAAP EPS was $0.32, down 39% from the previous year. Bruker announced a cost savings initiative aimed at reducing annual costs by $100 million to $120 million by fiscal year 2026, expecting this to enhance margins and potentially lead to double-digit EPS growth even in a muted revenue growth scenario.

Strong Performance in CALID Group

First half '25 CALID Group revenue increased in the low teens percentage with strong growth in microbiology and infection diagnostics driven by the MALDI Biotyper and the Bruker ELITech Molecular Diagnostics business.

Cost Savings Initiative

Bruker announced a significantly expanded cost savings initiative expected to reduce annual costs by $100 million to $120 million for fiscal year 2026.

Innovation and Product Launches

Bruker launched new and market-changing instruments at ASMS, enhancing its competitive position in proteomics and metabolomics.

Resilience in Diagnostic Markets

Strong placements and growth in diagnostics, especially in the ELITech Molecular Diagnostics business, with placements way ahead of plan.

Bruker (BRKR) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

BRKR Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 30, 2025	2025 (Q3)	0.33 / -	0.6	―	―	―
Aug 04, 2025	2025 (Q2)	0.41 / 0.32	0.52	-38.46% (-0.20)
May 07, 2025	2025 (Q1)	0.44 / 0.47	0.53	-11.32% (-0.06)
Feb 13, 2025	2024 (Q4)	0.74 / 0.76	0.7	8.57% (+0.06)
Nov 05, 2024	2024 (Q3)	0.60 / 0.60	0.74	-18.92% (-0.14)
Aug 06, 2024	2024 (Q2)	0.51 / 0.52	0.5	4.00% (+0.02)
May 02, 2024	2024 (Q1)	0.47 / 0.53	0.64	-17.19% (-0.11)
Feb 13, 2024	2023 (Q4)	0.68 / 0.70	0.74	-5.41% (-0.04)
Nov 02, 2023	2023 (Q3)	0.63 / 0.74	0.66	12.12% (+0.08)
Aug 03, 2023	2023 (Q2)	0.49 / 0.50	0.45	11.11% (+0.05)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

BRKR Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 04, 2025	$37.99	$34.72	-8.61%
May 07, 2025	$39.40	$40.71	+3.32%
Feb 13, 2025	$51.53	$51.03	-0.97%
Nov 05, 2024	$59.16	$61.14	+3.35%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Bruker Corporation (BRKR) report earnings?

Bruker Corporation (BRKR) is schdueled to report earning on Oct 30, 2025, After Close (Confirmed).

What is Bruker Corporation (BRKR) earnings time?

Bruker Corporation (BRKR) earnings time is at Oct 30, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is BRKR EPS forecast?

BRKR EPS forecast for the fiscal quarter 2025 (Q3) is 0.33.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing